Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet

Go back to Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet
(NASDAQ: HIND) Delayed: 2.25 -0.03 (1.32%)
Previous Close $2.28    52 Week High
Open $2.21    52 Week Low
Day High $2.30    P/E N/A 
Day Low $2.21    EPS
Volume 4,689